4

Changes in Ownership

Coherus Oncology, Inc. Filed 2014-11-12 Acc 0001209191-14-067904

Director acquired 2,500,920 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Troendle August J. Director	2014-11-12	Conversion	+319,935			319,935	I
Troendle August J. Director	2014-11-12	Conversion	+1,556,055			1,875,990	I
Troendle August J. Director	2014-11-12	Conversion	+266,502			2,142,492	I
Troendle August J. Director	2014-11-12	Conversion	+358,428			358,428	I
Derivatives
Troendle August J. Director	2014-11-12	Option exercise · Warrant to Purchase Series B Preferred Stock	−107,528			0	I
Troendle August J. Director	2014-11-12	Option exercise · Series B Preferred Stock	+107,528	$0.02	$1,796	1,556,055	I
Troendle August J. Director	2014-11-12	Conversion · Series A Preferred Stock	−319,935			0	I
Troendle August J. Director	2014-11-12	Conversion · Series B Preferred Stock	−1,556,055			0	I
Troendle August J. Director	2014-11-12	Conversion · Series C Preferred Stock	−266,502			0	I
Troendle August J. Director	2014-11-12	Conversion · Series B Preferred Stock	−358,428			0	I